Proteomic analysis of proteins secreted by HepG2 cells treated with butyl benzyl phthalate

Journal of Toxicology and Environmental Health - Part A: Current Issues

Volumn 73, Issue 21-22, 2010, Pages 1570-1585

  Choi, Seonyoung ^a   Park, So Young ^a   Kwak, Dongsub ^b   Phark, Sohee ^b   Lee, Min ^b   Lim, Ji Youn ^b   Jung, Woon Won ^c   Sul, Donggeun ^b  

^a Department of Nanobiomedical Science   (South Korea)

^b Korea University College of Medicine   (South Korea)

^c Korea University   (South Korea)

Author keywords

[No Author keywords available]

Indexed keywords

CYSTATIN C; FLAVOPROTEIN; GELSOLIN; INTER ALPHA TRYPSIN INHIBITOR; PHTHALIC ACID BENZYL BUTYL ESTER; PROTEIN DEK; PROTEIN SERINE THREONINE KINASE; RAF PROTEIN; RHO GUANINE NUCLEOTIDE BINDING PROTEIN; TRIOSEPHOSPHATE ISOMERASE; UNCLASSIFIED DRUG; FORMAZAN; MTT FORMAZAN; PHTHALIC ACID DERIVATIVE; PROTEOME; TERATOGENIC AGENT; TETRAZOLIUM; TUMOR MARKER;

ANIMAL EXPERIMENT; APOPTOSIS; ARTICLE; CELL MOTILITY; CELL STRUCTURE; CONCENTRATION (PARAMETERS); CONTROLLED STUDY; CYTOTOXICITY; DNA DAMAGE; DOWN REGULATION; ELECTRON TRANSPORT; ELECTROSPRAY MASS SPECTROMETRY; ENERGY METABOLISM; HUMAN; HUMAN CELL; MALE; MASS SPECTROMETRY; NONHUMAN; PRIORITY JOURNAL; PROTEIN ANALYSIS; PROTEIN EXPRESSION; PROTEIN SECRETION; PROTEOMICS; RAT; TUMOR GROWTH; TWO DIMENSIONAL GEL ELECTROPHORESIS; UPREGULATION; WESTERN BLOTTING; ANIMAL; CELL SURVIVAL; CHEMISTRY; COMET ASSAY; DRUG EFFECTS; HEPG2 CELL LINE; ISOELECTRIC FOCUSING; LIVER TUMOR; METABOLISM; MICROARRAY ANALYSIS; PEPTIDE MAPPING; SILVER STAINING; SPRAGUE DAWLEY RAT; TANDEM MASS SPECTROMETRY; TOXICITY;

ANIMALS; BLOTTING, WESTERN; CELL SURVIVAL; COMET ASSAY; DNA DAMAGE; ELECTROPHORESIS, GEL, TWO-DIMENSIONAL; FORMAZANS; HEP G2 CELLS; HUMANS; ISOELECTRIC FOCUSING; LIVER NEOPLASMS; MALE; MICROARRAY ANALYSIS; PEPTIDE MAPPING; PHTHALIC ACIDS; PROTEOME; PROTEOMICS; RATS; RATS, SPRAGUE-DAWLEY; SILVER STAINING; SPECTROMETRY, MASS, ELECTROSPRAY IONIZATION; TANDEM MASS SPECTROMETRY; TERATOGENS; TETRAZOLIUM SALTS; TUMOR MARKERS, BIOLOGICAL;

EID: 77958171659     PISSN: 15287394     EISSN: 10872620     Source Type: Journal    
DOI: 10.1080/15287394.2010.511583     Document Type: Article

References (51)

1. Al-Mulla, F., Hagan, S., Behbehani, A. I., Bitar, M. S., George, S. S., Going, J. J., Garcia, J. J., Scott, L., Fyfe, N., Murray, G. I., and Kolch, W. 2006. Raf kinase inhibitor protein expression in a survival analysis of colorectal cancer patients. J. Clin. Oncol. 24:5672-5679.
2. Anderson, D., Yu, T. W., and Hincal, F. 1999. Effect of some phthalate esters in human cells in the comet assay. Teratogen. Carcinogen. Mutagen. 19:275-280.
3. Benninghoff, A. D. 2007. Toxicoproteomics-The next step in the evolution of environmental biomarkers. Toxicol. Sci. 95:1-4.
4. Bost, F., Diarra-Mehrpour, M., and Martin, J. P. 1998. Inter-alpha-trypsin inhibitor proteoglycan family-A group of proteins binding and stabilizing the extracellular matrix. Eur. J. Biochem. 252:339-346.
5. Bradford, M. M. 1976. A rapid and sensitive for the quantitation of microgram quantities of protein utilizing the principle of protein-dye binding. Anal. Biochem. 72:248-254.
6. Bucki, R., Levental, I., Kulakowska, A., and Janmey, P. A. 2008. Plasma gelsolin: Function, prognostic value, and potential therapeutic use. Curr. Protein Peptide Sci. 9:541-551.
7. Choi, S. M., Yoo, S. D., and Lee, B. M., 2004. Toxicological characteristics of endocrinedisrupting chemicals: Developmental toxicity, carcinogenicity, and mutagenicity. J. Toxicol. Environ. Health B 7:1-32.
8. Eigenberg, D. A., Bozigian, H. P., Carter, D. E., and Sipes, I. G. 1986. Distribution, excretion, and metabolism of butylbenzyl phthalate in the rat. J. Toxicol. Environ. Health 17:445-456.
9. Fu, Z., Dozmorov, I. M., and Keller, E. T. 2002. Osteoblasts produce soluble factors that induce a gene expression pattern in non-metastatic prostate cancer cells, similar to that found in bone metastatic prostate cancer cells. Prostate 51:10-20.
10. Fu, Z., Kitagawa, Y., Shen, R., Shah, R., Mehra, R., Rhodes, D., Keller, P. J., Mizokami, A., Dunn, R., Chinnaiyan, A. M., Yao, Z., and Keller, E. T. 2006. Metastasis suppressor gene Raf kinase inhibitor protein (RKIP) is a novel prognostic marker in prostate cancer. Prostate 66:248-256.
11. Hamm, A., Veeck, J., Bektas, N., Wild, P. J., Hartmann, A., Heindrichs, U., Kristiansen, G., Werbowetski-Ogilvie, T., Del Maestro, R., Knuechel, R., and Dahl, E. 2008. Frequent expression loss of Inter-alphatrypsin inhibitor heavy chain (ITIH) genes in multiple human solid tumors: A systematic expression analysis. BMC Cancer 8:25.
12. Ishizaki, K., Schauer, N., Larson, T. R., Graham, I. A., Fernie, A. R., and Leaver, C. J. 2006. The mitochondrial electron transfer flavoprotein complex is essential for survival of Arabidopsis in extended darkness. Plant J. 47:751-760.
13. Johnson, J. L., Erickson, J. W., and Cerione, R. A. 2009. New insights into how the Rho guanine nucleotide dissociation inhibitor regulates the interaction of Cdc42 with membranes. J. Biol. Chem. 284:23860-23871.
14. Kai, H., Shono, T., Tajiri, T., and Suita, S. 2005. Long-term effects of intrauterine exposure to mono-n-butyl phthalate on the reproductive function of postnatal rats. J. Pediatr. Surg. 40:429-433.
15. Kang, S. C., and Lee, B. M. 2005. DNA methylation of estrogen receptor alpha gene by phthalates. J. Toxicol. Environ. Health A 68:1995-2003.
16. Kappes, F., Fahrer, J., Khodadoust, M. S., Tabbert, A., Strasser, C., Mor-Vaknin, N., Moreno-Villanueva, M., Burkle, A., Markovitz, D. M., and Ferrando-May, E. 2008. DEK is a poly (ADP-ribose) acceptor in apoptosis and mediates resistance to genotoxic stress. Mol. Cell. Biol. 28:3245-3257.
17. Kavlock, R., Barr, D., Boekelheide, K., Breslin, W., Breysse, P., Chapin, R., Gaido, K., Hodgson, E., Marcus, M., Shea, K., and Williams, P. 2006. NTP-CERHR Expert Panel update on the reproductive and developmental toxicity of di (2-ethylhexyl) phthalate. Reprod. Toxicol. 22:291-399.
18. Kennedy, S. 2002. The role of proteomics in toxicology: Identification of biomarkers of toxicity by protein expression analysis. Biomarkers 7:269-290.
19. Kim, D. W., Chae, J. I., Kim, J. Y., Pak, J. H., Koo, D. B., Bahk, Y. Y., and Seo, S. B. 2009. Proteomic analysis of apoptosis related proteins regulated by proto-oncogene protein DEK. J. Cell. Biochem. 106:1048-1059.
20. Knasmuller, S., Mersch-Sundermann, V., Kevekordes, S., Darroudi, F., Huber, W. W., Hoelzl, C., Bichler, J., and Majer, B. J. 2004. Use of human-derived liver cell lines for the detection of environmental and dietary genotoxicants; current state of knowledge. Toxicology 198:315-328.
21. Koo, H. J., and Lee, B. M. 2004. Estimated exposure to phthaiates in cosmetics and risk assessment. J. Toxicol. Environ. Health A 67:1901-1914.
22. Koya, R. C., Fujita, H., Shimizu, S., Ohtsu, M., Takimoto, M., Tsujimoto, Y., and Kuzumaki, N. 2000. Gelsolin inhibits apoptosis by blocking mitochondrial membrane potential loss and cytochrome c release. J. Biol. Chem. 275:15343-15349.
23. Li, G. H., Shi, Y., Chen, Y., Sun, M., Sader, S., Maekawa, Y., Arab, S., Dawood, F., Chen, M., De Couto, G., Liu, Y., Fukuoka, M., Yang, S., Da Shi, M., Kirshenbaum, L. A., McCulloch, C. A., and Liu, P. 2009a. Gelsolin regulates cardiac remodeling after myocardial infarction through DNase I-mediated apoptosis. Circ. Res. 104:896-904.
24. Li, H. Z., Gao, Y., Zhao, X. L., Liu, Y. X., Sun, B. C., Yang, J., and Yao, Z. 2009b. Effects of raf kinase inhibitor protein expression on metastasis and progression of human breast cancer. Mol. Cancer Res. 7:832-840.
25. Lu, H., Yang, Y., Allister, E. M., Wijesekara, N., and Wheeler, M. B. 2008. The identification of potential factors associated with the development of type 2 diabetes: A quantitative proteomics approach. Mol. Cell Proteomics 7:1434-1451.
26. Muranjan, M., Nussenzweig, V., and Tomlinson, S. 1998. Characterization of the human serum trypanosome toxin, haptoglobin-related protein. J. Biol. Chem. 273:3884-3887.
27. Mylchreest, E., Cattley, R. C., and Foster, P. M. 1998. Male reproductive tract malformations in rats following gestational and lactational exposure to di (n-butyl) phthalate: An antiandrogenic mechanism? Toxicol. Sci. 43:47-60.
28. Naruse, H., Ishii, J., Kawai, T., Hattori, K., Ishikawa, M., Okumura, M., Kan, S., Nakano, T., Matsui, S., Nomura, M., Hishida, H., and Ozaki, Y. 2009. Cystatin C in acute heart failure without advanced renal impairment. Am. J. Med. 122:566-573.
29. Nishiyama, K., Konishi, A., Nishio, C., Araki-Yoshida, K., Hatanaka, H., Kojima, M., Ohmiya, Y., Yamada, M., and Koshimizu, H. 2005. Expression of cystatin C prevents oxidative stress-induced death in PC12 cells. Brain Res. Bull. 67:94-99.
30. Orosz, F., Olah, J., and Ovadi, J. 2006. Triosephosphate isomerase deficiency: Facts and doubts. IUBMB Life 58:703-715.
31. Park, S. Y., Kim, H. S., Cho, E. K., Kwon, B. Y., Phark, S., Hwang, K. W., and Sul, D. 2008. Curcumin protected PC12 cells against beta-amyloid-induced toxicity through the inhibition of oxidative damage and tau hyperphosphorylation. Food Chem. Toxicol. 46:2881-2887.
32. Phillips, K. P., and Tanphaichitr, N. 2008. Human exposure to endocrine disruptors and semen quantity. J. Toxicol. Environ. Health B 11:188-220.
33. Pretsch, W. 2009. Triosephosphate isomerase activity-deficient mice show haemolytic anaemia in homozygous condition. Genet. Res. 91:1-4.
34. Sabbieti, M. G., Agas, D., Santoni, G., Materazzi, S., Menghi, G., and Marchetti, L. 2009. Involvement of p53 in phthalate effects on mouse and rat osteoblasts. J. Cell. Biochem. 107:316-327.
35. Saillenfait, A. M., Sabate, J. P., and Gallissot, F. 2003. Comparative embryotoxicities of butyl benzyl phthalate, mono-n-butyl phthalate and mono-benzyl phthalate in mice and rats: In vivo and in vitro observations. Reprod. Toxicol. 17:575-583.
36. Schiff, M., Froissart, R., Olsen, R. K., Acquaviva, C., and Vianey-Saban, C. 2006. Electron transfer flavoprotein deficiency: Functional and molecular aspects. Mol. Genet. Metab. 88:153-158.
37. Singh, N., Manshian, B., Jenkins, G. J., Griffiths, S. M., Williams, P. M., Maffeis, T. G., Wright, C. J., and Doak, S. H. 2009. Nanogenotoxicology: the DNA damaging potential of engineered nanomaterials. Biomaterials 30:3891-3914.
38. Tohdoh, N., Tojo, S., Agui, H., and Ojika, K. 1995. Sequence homology of rat and human HCNP precursor proteins, bovine phosphatidylethanolamine-binding protein and rat 23-kDa protein associated with the opioid-binding protein. Brain Res. Mol. Brain Res. 30:381-384.
39. Tsuji-Akimoto, S., Yabe, I., Niino, M., Kikuchi, S., and Sasaki, H. 2009. Cystatin C in cerebrospinal fluid as a biomarker of ALS. Neurosci. Lett. 452:52-55.
40. Tyl, R. W., Myers, C. B., Marr, M. C., Fail, P. A., Seely, J. C., Brine, D. R., Barter, R. A., and Butala, J. H. 2004. Reproductive toxicity evaluation of dietary butyl benzyl phthalate (BBP) in rats. Reprod. Toxicol. 18:241-264.
41. Tyrkiel, E. J., Dobrzynska, M. M., Derezinska, E., and Ludwicki, J. K. 2007. Effects of subchronic exposure of laboratory mice to benzylbutyl phthalate (BBP) on the quantity and quality of male germ cells. Rocz. Panstw. Zakl. Hig. 58:677-686 (in Polish).
42. Waldmann, T., Scholten, I., Kappes, F., Hu, H. G., and Knippers, R. 2004. The DEK protein-An abundant and ubiquitous constituent of mammalian chromatin. Gene 343:1-9.
43. Wang, H., Chumnarnsilpa, S., Loonchanta, A., Li, Q., Kuan, Y. M., Robine, S., Larsson, M., Mihalek, I., Burtnick, L. D., and Robinson, R. C. 2009. Helix straightening as an activation mechanism in the gelsolin superfamily of actin regulatory proteins. J. Biol. Chem. 284:21265-21269.
44. Witte, I., Plappert, U., de Wall, H., and Hartmann, A. 2007. Genetic toxicity assessment: Employing the bestscience for human safety evaluation, part III: The comet assay as an alternative to in vitro clastogenicity tests for early drug candidate selection. Toxicol. Sci. 97:21-26.
45. Yashiro, M., Kamata, T., Segawa, H., Kadoya, Y., Murakami, T., and Muso, E. 2009. Comparisons of cystatin C with creatinine for evaluation of renal function in chronic kidney disease. Clin. Exp. Nephrol. 13:598-604.
46. Zacharewski, T. R., Meek, M. D., Clemons, J. H., Wu, Z. F., Fielden, M. R., and Matthews, J. B. 1998. Examination of the in vitro and in vivo estrogenic activities of eight commercial phthalate esters. Toxicol. Sci. 46:282-293.
47. Zerovnik, E. 2009. The emerging role of cystatins in Alzheimer's disease. Bioessays 31:597-599.
48. Zhang, B. 2006. Rho GDP dissociation inhibitors as potential targets for anticancer treatment. Drug Resist. Update 9:134-141.
49. Zhao, L., Wang, H., Li, J., Liu, Y., and Ding, Y. 2008. Overexpression of Rho GDP-dissociation inhibitor alpha is associated with tumor progression and poor prognosis of colorectal cancer. J. Proteome Res. 7:3994-4003.
50. Zhuo, L., Hascall, V. C., and Kimata, K. 2004. Inter-alpha-trypsin inhibitor, a covalent protein-glycosaminoglycan-protein complex. J. Biol. Chem. 279:38079-38082.
51. Zwickl, H., Traxler, E., Staettner, S., Parzefall, W., Grasl-Kraupp, B., Karner, J., Schulte-Hermann, R., and Gerner, C. 2005. A novel technique to specifically analyze the secretome of cells and tissues. Electrophoresis 26:2779-2785.